Update on Medical Director Search

  • David Walton shared that has spoken with potential candidates for the Medical Director role over the last two months
  • Goal of filling role in Q3-Q4 2025

 

T1DX-QI’s presence at ADA Scientific Sessions

  • Oral presentations and posters.
  • 276-OR; T2D, Dr. Odugbesan, 6/22 at 4pm

T1D Exchange is hosting a breakfast at the ADA Sci Sessions

  • Sunday morning, June 22nd, from 6:30 -8: 00 am (Central Time.)
  • Woven + Bound, Marriott Marquis. Please RSVP here.

 

Save the date for the November Learning Session Nov 11-12, Atlanta, GA

  • T1DX will cover hotel nights for two attendees for two nights. Teams are welcome to bring additional members.
  • Registration for conference will begin after 6/1

 

Update on Aims, KDDs, and Measures: current measures expire 1/1/26

  • Clinical Leaders will be invited to a meeting, reviewing Aims and Measures in Q3
  • Feedback
  • Suggestion that we consider moving aim from 7% to 6.5% for A1c goal, to match current Standard of Care

 

Sponsored project opportunities:

  • Obesity and T2D with GLP1 prescribing project will be submitted to Eli Lilly in May. T1DX will share a call for interest for this project with the centers in a Qualtrics link within the next month.
  • T1D Exchange has set a goal of mapping 6 centers for T2D data in 2025.
  • There are opportunities for pediatric and adult clinics to map T2D data to be eligible to participate in more funded projects.
  • If you are interested in beginning the data mapping process for T2D, please email QI@t1dexchange.org
  • New Diabetes and Screening project will be submitted for funding in June. T1DX will share a call for interest for this project with the centers in a Qualtrics link within the next month.
  • 4-5 centers will be invited, looking at screening numbers, monitoring, DKA events, and treatment, etc.
  • Overview of current projects
  • BPA-TECH: Best Practice Advisories for Tech Equity
  • Aim to develop and implement an EHR-based BPA using stakeholder feedback to standardize the approach for prescribing and documenting advanced diabetes technologies among PwT1D.
  • 8 participating centers
  • Diabetes Screening
  • Increase by 15% from baseline
  • 6 participating centers